Search

everythinglearnresearchcommunity

for

Search:↓

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

STAT5 activation is crucial for starting the hair growth phase.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Ruxolitinib treatment may cause eyelash growth.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Some medicinal plants can help heal wounds and may lead to new treatments.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Rhamnose may help hair growth and pigmentation, making it a potential treatment for hair loss.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

New regenerative therapies show promise for treating hair loss.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.